19 BPU441462.indd
ثبت نشده
چکیده
Background: End-stage renal disease (ESRD) patients have poor health-related quality of life (HRQOL) comparing to general population and comparable HRQOL to patients with other major chronic diseases. Poor HRQOL is associated with shorter survival. There is a limited threshold to which dialysis dose and parameters management can improve HRQOL in ESRD patients. Numerous studies have sought to find interventions to improve HRQOL. This article is to review the symptoms associated with poor HRQOL and how frequent the quality of life (QOL) should be evaluated to improve the outcome. Summary: It is required by the Center for Medicare and Medicaid Services to evaluate HRQOL of dialysis patients annually. KDIGO recommends the symptoms to be assessed regularly and the treatment is redirected toward a patient-centered care model. Studies have shown that measuring patient-reported outcomes frequently, from 4 times a day to every 3–6 months, without intervention did not improve the HRQOL significantly. Appropriate intervention of the symptoms may improve the quality of life (QOL). Studies Published online: January 15, 2016 Shan Shan Chen Nephrology Division, Department of Medicine University of New Mexico School of Medicine 901 University Blvd SE, Albuquerque, NM 87106 (USA) E-Mail sschen @ salud.unm.edu © 2016 S. Karger AG, Basel 0253–5068/16/0413–0218$39.50/0
منابع مشابه
19 BPU441462.indd
Background: End-stage renal disease (ESRD) patients have poor health-related quality of life (HRQOL) comparing to general population and comparable HRQOL to patients with other major chronic diseases. Poor HRQOL is associated with shorter survival. There is a limited threshold to which dialysis dose and parameters management can improve HRQOL in ESRD patients. Numerous studies have sought to fi...
متن کامل19 BPU441462.indd
Background: End-stage renal disease (ESRD) patients have poor health-related quality of life (HRQOL) comparing to general population and comparable HRQOL to patients with other major chronic diseases. Poor HRQOL is associated with shorter survival. There is a limited threshold to which dialysis dose and parameters management can improve HRQOL in ESRD patients. Numerous studies have sought to fi...
متن کاملSynthesis and Reactions of 3-Unsubstituted 2-Isoxazolines
Pohjakallio_176x250.indd 3 4.3.2011 10.34 Abstract_Pohjakallio_176x250.indd 3 4.3.2011 10.34Pohjakallio_176x250.indd 3 4.3.2011 10.34 2-Isoksatsoliinit ovat heterosyklisiä yhdisteitä, joita voidaan käyttää monipuolisesti synteettisinä välivaiheina erilaisten hyödyllisten rakenneyksiköiden valmistamisessa. 2-Isoksatsoliinien hyödyllisyys on pitkään perustunut niiden helppoon synteesiin erityises...
متن کاملIntranasal drug delivery in neuropsychiatry: focus on intranasal ketamine for refractory depression.
Intranasal drug delivery (INDD) systems offer a route to the brain that bypasses problems related to gastrointestinal absorption, first-pass metabolism, and the blood-brain barrier; onset of therapeutic action is rapid, and the inconvenience and discomfort of parenteral administration are avoided. INDD has found several applications in neuropsychiatry, such as to treat migraine, acute and chron...
متن کامل